Tag Archives: Steve Jobs medical leave

Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients

The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread  (metastasized) to other parts of the body.  Steve … Continue reading

Posted in carcinoid and neuroendocrine tumor treatments | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | 2 Comments

Carcinoid Cancer Foundation Thanks Steve Jobs for Bringing about Greater Awareness of Neuroendocrine Cancers

Since the announcement was made earlier this month that Apple’s CEO Steve Jobs would be taking a medical leave of absence there has been significant media coverage about pancreatic neuroendocrine tumors, NET cancer, and carcinoid.  Although he has not talked … Continue reading

Posted in cancer, carcinoid and neuroendocrine tumor treatments, carcinoid awareness, carcinoid cancer, Carcinoid Cancer Foundation, carcinoid tumor, carcinoid websites, NET (neuroendocrine tumor) cancer, neuroendocrine cancer, neuroendocrine cancer awareness, neuroendocrine tumor cancer awareness, rare cancers, rare diseases | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 6 Comments